|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2004-12-30
|
|
pubmed:abstractText |
As part of a synthesis of evidence regarding the efficacy and safety of ephedra, the authors describe data on psychiatric adverse events from reports submitted to the Food and Drug Administration (FDA).
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0002-953X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
162
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
189-91
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:15625222-Adult,
pubmed-meshheading:15625222-Adverse Drug Reaction Reporting Systems,
pubmed-meshheading:15625222-Dietary Supplements,
pubmed-meshheading:15625222-Ephedra,
pubmed-meshheading:15625222-Female,
pubmed-meshheading:15625222-Humans,
pubmed-meshheading:15625222-Male,
pubmed-meshheading:15625222-Mental Disorders,
pubmed-meshheading:15625222-Middle Aged,
pubmed-meshheading:15625222-Plant Preparations,
pubmed-meshheading:15625222-United States,
pubmed-meshheading:15625222-United States Food and Drug Administration
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Psychiatric effects of ephedra use: an analysis of Food and Drug Administration reports of adverse events.
|
|
pubmed:affiliation |
RAND, Santa Monica, CA 90407, USA. maglione@rand.org
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|
